← Volver a los artículos

health

Health & Medicine

The FDA has approved a new drug that could extend survival for late-stage pancreatic cancer patients, offering potential hope for a disease with historically poor outcomes.

HIGH confianza neutral tono

Cobertura (16521 artículos)

The Canberra Times · Aug 02, 2026

Rare brain cancer treatment now affordable via PBS subsidy

A targeted drug for rare brain cancer has been added to Australia's subsidized medicines scheme, reducing monthly costs from $28,000 to affordable levels and offering hope to 135 newly diagnosed patients annually.

← Anterior Página 147 de 689 Siguiente →
Contáctanos FAQ